Ovarian Cancer Education Ira Winer, M.D., Ph.D., FACOG , gynecologic oncologist and member of the Gynecologic Oncology and Phase I Clinical-Pharmacology Multidisciplinary Teams at Karmanos Cancer Institute, along with Jennifer Land, RN, a clinical trials nurse at Karmanos, are featured on an episode of the Ovarian Cancer Education Podcast to discuss clinical trials. Listen to the podcast episode here. Click here to learn more about clinical trials at Barbara Ann Karmanos Cancer Institute.
CancerNetwork Ira Winer, M.D., Ph.D., FACOG , member of the Gynecologic Oncology and Phase I Clinical-Pharmacology Multidisciplinary Teams at Karmanos, spoke about the future directions of nemvaleukin alfa plus pembrolizumab for patients with pretreated resistant ovarian cancer. Listen to his interview with CancerNetwork here .
CancerNetwork Ira Winer, M.D., Ph.D., FACOG , member of the Gynecologic Oncology Multidisciplinary Team at Karmanos, recently presented Clinical Outcomes of Ovarian Cancer Patients Treated with the Novel Engineered Cytokine Nemvaleukin Alfa in Combination with the PD-1 Inhibitor Pembrolizumab: Recent Data from ARTISTRY-1 at The Society of Gynecologic Oncology (SGO) 2022 Annual Meeting on Women’s Cancer. Following the conference, Dr. Winer speaks to the CancerNetwork about the presentations he found most...